The role of suPAR in kidney diseases

Journal Title: Annales Academiae Medicae Silesiensis - Year 2017, Vol 71, Issue

Abstract

Chronic kidney disease (CKD) is unquestionably a problem of social significance because it affects about 10% of the population. There is a search for biomarkers which could help select persons out of such a large group of patients with a high risk of disease progression and of its complications. The major cause of death in patients with end-stage renal disease are cardiovascular diseases. Accelerated atherosclerosis in this group of patients is associated with a chronic inflammatory state. The new biological marker of inflammation suPAR (soluble urokinase-type plasminogen activator receptor), is the focus of attention of the authors of this report. The relationship of suPAR with urinary tract infections and focal segmental glomerulosclerosis is also very interesting from the clinical perspective. The perception of suPAR as a blood circulating factor, inducing FSGS, throws new light on the pathomechanism of this medical condition, while unveiling promising therapeutic perspectives. A better understanding of the pathogenesis of the diseases discussed will help to reduce the unacceptably high mortality rate in patients with CKD. At present, common assaying of suPAR is not yet possible in the context of the above-mentioned issues. Nevertheless, studies are ongoing which may explain the still unclear issues concerning the relationship of the biomarker with the mentioned kidney diseases. Perhaps, follo-wing their results suPAR assays may in the near future become routine diagnostics means in selected kidney diseases.

Authors and Affiliations

Beata Łącka-Gaździk, Mirosław Śnit, Magdalena Żak-Lenart, Władysław Grzeszczak

Keywords

Related Articles

Analysis of impact of unit dose drug distribution system on pharmacotherapy optimization

INTRODUCTION: A unit dose system enables the delivery of drugs from the hospital pharmacy to the hospital unit for a particular patient. Each dose is separately packaged and labeled with general information about the dru...

Materiały do flory roślin naczyniowych Wyżyny Śląskiej ze szczególnym uwzględnieniem roślin leczniczych; część 1. Dolina Potoku Psarskiego

WSTĘP: W pracy przedstawiono wyniki badań florystycznych, przeprowadzonych w Dolinie Potoku Psarskiego w Będzinie. Opisano florę naczyniową badanego terenu, ze szczególnym uwzględnieniem gatunków roślin leczniczych, a ta...

12-month assessment of increase in total kidney volume in children and young adults with autosomal dominant polycystic kidney disease – a pilot study

INTRODUCTION: Autosomal dominant polycystic kidney disease (ADPKD) is the most common type of monogenic kidney disease. It is the cause of ESRD in 5–10% of adult patients who undergo renal replacement therapy. Owing to t...

Rs2058539 and rs10953505 visfatin gene polymorphisms their plasma concentrations and occurrence of overweight and obesity among patients reporting to primary healthcare clinic

INTRODUCTION: Visfatin is a newly discovered adipocytokine displaying insulino-mimetic properties. The role of the investigated polymorphisms in visfatin coding genes and their blood plasma levels in the development of i...

Arterial blood pressure circadian rhythm in normotensive decompensated cirrhotic patients before and after single paracentesis

INTRODUCTION: Decompensated liver cirrhosis is associated with hemodynamic changes including arterial blood pressure alterations. The aim of the study was to investigate the circadian rhythm variability of arterial blood...

Download PDF file
  • EP ID EP360074
  • DOI 10.18794/aams/65841
  • Views 105
  • Downloads 0

How To Cite

Beata Łącka-Gaździk, Mirosław Śnit, Magdalena Żak-Lenart, Władysław Grzeszczak (2017). The role of suPAR in kidney diseases. Annales Academiae Medicae Silesiensis, 71(), 265-270. https://europub.co.uk/articles/-A-360074